Give me tought medicine pg question

Reading File

Here's a tough PG-level medicine question for you:

Question

A 34-year-old woman presents with a 3-month history of progressive dyspnea on exertion, fatigue, and mild bilateral ankle swelling. She has no chest pain, cough, or fever. Past history is significant for recurrent oral ulcers and a malar rash 2 years ago, for which she was started on hydroxychloroquine.

On examination:

BP: 148/96 mmHg
JVP: raised
Fine bibasilar crackles
S3 gallop present
Mild pitting edema up to the ankles

Investigations:

Hb: 9.2 g/dL (normocytic normochromic)
WBC: 3,400/mm³
Platelets: 98,000/mm³
Serum creatinine: 2.4 mg/dL (baseline 1 year ago: 0.9 mg/dL)
Urine: 3+ proteinuria, RBC casts on microscopy
Complement C3: low, C4: low
Anti-dsDNA: 4× upper limit of normal
Echo: EF 35%, mild pericardial effusion, global hypokinesia

What is the SINGLE MOST LIKELY unifying diagnosis, and which class of lupus nephritis (ISN/RPS classification) is most consistent with the urinalysis findings? What is the first-line immunosuppressive induction regimen of choice, and which cardiac complication in SLE carries the highest risk of systemic embolism?

Answer

Scroll down...

1. Unifying Diagnosis

Systemic Lupus Erythematosus (SLE) with:

Lupus nephritis (active sediment: RBC casts + heavy proteinuria + rising creatinine)
Lupus cardiomyopathy (EF 35%, S3, global hypokinesia)
Cytopenias (hemolytic anemia + leukopenia + thrombocytopenia = classic lupus hematologic involvement)

2. ISN/RPS Lupus Nephritis Class

Class IV - Diffuse Proliferative Lupus Nephritis

Most severe and most common class causing nephritic syndrome
Features: RBC casts, heavy proteinuria, rising creatinine, low C3/C4, high anti-dsDNA
Histology: "wire loop" lesions, subendothelial immune complex deposits, mesangial hypercellularity affecting >50% of glomeruli
Class III = focal (<50% glomeruli); Class IV = diffuse (≥50% glomeruli) - this presentation with significant renal impairment points to Class IV

3. First-Line Induction Regimen

Mycophenolate mofetil (MMF) 2-3 g/day + high-dose corticosteroids (IV methylprednisolone 500-1000 mg × 3 days, then oral prednisolone 0.5-1 mg/kg/day)

MMF is now preferred over cyclophosphamide in most centers (equivalent efficacy, better tolerability, less gonadotoxicity)
Euro-Lupus low-dose IV cyclophosphamide is an alternative, especially in European populations
Hydroxychloroquine should be continued throughout (renoprotective, reduces flares)
Belimumab (anti-BLyS) can be added as adjunct in refractory cases

4. Cardiac Complication with Highest Risk of Systemic Embolism

Libman-Sacks Endocarditis (non-bacterial thrombotic endocarditis)

Sterile verrucous vegetations on the mitral valve (posterior leaflet, both surfaces - distinguishes it from infective endocarditis which affects the valve closure line)
Strongly associated with antiphospholipid antibody syndrome (APS) co-existing with SLE
Carries high risk of systemic emboli - stroke, renal infarcts, splenic infarcts
Note: This patient also has thrombocytopenia, raising suspicion for secondary APS - check anticardiolipin antibodies and lupus anticoagulant

Why This is Tough

The question tests four domains simultaneously:

Recognizing multi-system SLE (nephritis + cardiomyopathy + cytopenia)
Applying ISN/RPS nephritis classification based on clinical clues (not biopsy)
Knowing current induction therapy (MMF vs cyclophosphamide debate)
Distinguishing Libman-Sacks from other cardiac SLE complications (pericarditis, myocarditis) and knowing its embolic risk link to APS

Want another tough question on a different topic - pharmacology, pathology, surgery, or a specific system?

I want mcq

Asking for Preferences

Here's a NEET PG-level Medicine MCQ:

Question

A 58-year-old man with a known history of type 2 diabetes and hypertension presents with sudden onset of severe headache, confusion, and right-sided weakness for 2 hours. His BP is 210/120 mmHg. CT brain (plain) shows a hyperdense lesion in the left basal ganglia. INR is 1.1. His medications include metformin, amlodipine, and aspirin 75 mg/day.

What is the MOST APPROPRIATE immediate management?

A. Stop aspirin, give IV alteplase (tPA) 0.9 mg/kg
B. Stop aspirin, start IV labetalol to reduce BP to <140/90 mmHg within 1 hour, and arrange urgent neurosurgical consultation
C. Give IV mannitol, continue aspirin, and target BP <180/105 mmHg
D. Stop aspirin, start IV labetalol to reduce BP by ~15-20% in the first hour, monitor closely

Think before scrolling...

✅ Correct Answer: D

Explanation

This is intracerebral hemorrhage (ICH) - the hyperdense lesion on plain CT = acute blood. This is NOT ischemic stroke, so tPA is absolutely contraindicated (eliminates A).

Key management points in ICH:

Issue	Action
Aspirin	Stop immediately (antiplatelet in active bleed)
BP target	Reduce gradually by 15-20% in the first hour; aggressive lowering risks ischemia in the penumbra
tPA	Absolutely contraindicated
Mannitol	Used for raised ICP / herniation signs - no clear indication here yet
Neurosurgery	Consult for basal ganglia bleeds >30 mL or deteriorating patients, but not the first step

Why not B? Targeting BP <140/90 within 1 hour is too aggressive for ICH. The current guideline (AHA/ASA) recommends reducing SBP to ~140-160 mmHg as a target, but the rate of reduction matters - rapid overcorrection can worsen outcome. A ~15-20% reduction in the first hour is the safe approach.

Why not C? Continuing aspirin in an active intracranial hemorrhage is harmful.

High-Yield ICH Facts for NEET PG

Most common cause of ICH: Hypertension (putamen/basal ganglia = most common site)
Hyperdense on CT = acute blood (within 72 hrs)
tPA is contraindicated in hemorrhagic stroke
Reversal of anticoagulation: Vitamin K + FFP (warfarin), Idarucizumab (dabigatran), Andexanet alfa (rivaroxaban/apixaban)
Surgical evacuation: considered if cerebellar hematoma >3 cm or lobar hematoma with mass effect

Want another MCQ or a full set of 5 questions on a specific Medicine topic?

This is a shared conversation. Sign in to Orris to start your own chat.